Patel Snehal: insider trades.
Patel Snehal reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 5 open-market purchases ($97K) and 0 sales, across 1 company.
- Transactions
- 5
- Purchases (P)
- 5
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Patel Snehal
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | Director, Officer, TenPercentOwner · CEO and CFO | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-29 | Greenwich LifeSciences, Inc. | P | 700 | $13.1 | 5,611,402 | Form 4 |
| 2026-07-28 | Greenwich LifeSciences, Inc. | P | 1,500 | $13.59 | 5,610,702 | Form 4 |
| 2026-07-27 | Greenwich LifeSciences, Inc. | P | 1,500 | $13.62 | 5,609,202 | Form 4 |
| 2026-07-24 | Greenwich LifeSciences, Inc. | P | 1,100 | $12.88 | 5,607,702 | Form 4 |
| 2026-07-23 | Greenwich LifeSciences, Inc. | P | 2,500 | $13.14 | 5,606,602 | Form 4 |
Questions
What stock did Patel Snehal buy or sell?
Patel Snehal reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 5 open-market purchases ($97K) and 0 sales, across 1 company.
Is Patel Snehal the same person as other filers with this name?
This page covers SEC CIK 1806920 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/patel-snehal-1806920.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.